PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-May-2023 Altasciences Receives 2023 CRO Leadership Award for Capabilities Businesswire
09-May-2023 Bancroft Capital Expands its Suite of Banking Services With the New Investment Banking Team Businesswire
09-May-2023 Energous Elevates IoT Wireless Power Networks to a Higher Level of Performance with New 2W PowerBridge Transmitter That Doubles Energizing Capability Compared With Currently Deployed Transmitters Businesswire
09-May-2023 GE HealthCare Names James Saccaro Vice President and Chief Financial Officer Businesswire
09-May-2023 Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera Businesswire
09-May-2023 Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer Businesswire
09-May-2023 Menarini Group Announces New Data on Elacestrant at 2023 ESMO Breast Cancer Congress and 2023 ASCO Annual Meeting Businesswire
09-May-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-May-2023 Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets  Businesswire
09-May-2023 Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM) Businesswire
09-May-2023 Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by U.S. Patient Advocacy Groups Businesswire
09-May-2023 Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure Businesswire
09-May-2023 Seismic Therapeutic Announces Presentation of Preclinical Data for Immunoglobin Sculpting Enzyme and Dual-Cell Bidirectional Antibody Programs at IMMUNOLOGY 2023 Businesswire
09-May-2023 Hamilton and Biosero Announce Co-Marketing Agreement to Optimize Automated Liquid Handling Workflows Businesswire
09-May-2023 Rallybio Reports First Quarter 2023 Financial Results Businesswire
09-May-2023 Anokion Announces New Clinical Data from the Phase 1 ACeD Trial Supporting KAN-101 as a Potential Disease-modifying Treatment for Celiac Disease Businesswire
09-May-2023 AdaptHealth Corp. Announces First Quarter 2023 Results Businesswire
09-May-2023 AdaptHealth Announces Stephen Griggs Will Step Down as CEO at the End of Second Quarter Businesswire
09-May-2023 Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress Businesswire
09-May-2023 Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update Businesswire